M Han|A W Partin - JoVE Visualize

Showing results (171-180 of 1,286) with videos related to

Pageof 129

Sort By:

Medical and Pediatric Oncology|January 1, 1993

The use of nuclear morphometry to predict prognosis in pediatric urologic malignancies: a reviewA W Partin, J P Gearhart, M P Leonard, et al.

Urology|March 1, 1997

Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosisH B Carter, A W Partin, A A Luderer, et al.

Urology|December 31, 1997

Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteinsA W Partin, J V Briggman, E N Subong, et al.

Electrophoresis|December 28, 1999

Exploratory data analysis groupware for qualitative and quantitative electrophoretic gel analysis over the Internet-WebGelP F Lemkin, J M Myrick, Y Lakshmanan, et al.

Hybridoma|January 8, 2000

Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassayT J Wang, H J Linton, J Payne, et al.

JAMA|May 14, 1997

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updateA W Partin, M W Kattan, E N Subong, et al.

The Journal of Urology|April 1, 1990

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasiaA W Partin, H B Carter, D W Chan, et al.

The Prostate|July 21, 2004

Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOFM B Gretzer, D W Chan, C L van Rootselaar, et al.

Urology|May 1, 1994

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastasesA W Partin, J D Pearson, P K Landis, et al.

Cancer|January 3, 2001

Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomyS R Potter, L A Mangold, M J Shue, et al.

Pageof 129

Showing results (171-180 of 1,286) with videos related to

Sort By:

Pageof 129

Medical and Pediatric Oncology|January 1, 1993

The use of nuclear morphometry to predict prognosis in pediatric urologic malignancies: a reviewA W Partin, J P Gearhart, M P Leonard, et al.

Urology|March 1, 1997

Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosisH B Carter, A W Partin, A A Luderer, et al.

Urology|December 31, 1997

Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteinsA W Partin, J V Briggman, E N Subong, et al.

Electrophoresis|December 28, 1999

Exploratory data analysis groupware for qualitative and quantitative electrophoretic gel analysis over the Internet-WebGelP F Lemkin, J M Myrick, Y Lakshmanan, et al.

Hybridoma|January 8, 2000

Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassayT J Wang, H J Linton, J Payne, et al.

JAMA|May 14, 1997

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updateA W Partin, M W Kattan, E N Subong, et al.

The Journal of Urology|April 1, 1990

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasiaA W Partin, H B Carter, D W Chan, et al.

The Prostate|July 21, 2004

Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOFM B Gretzer, D W Chan, C L van Rootselaar, et al.

Urology|May 1, 1994

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastasesA W Partin, J D Pearson, P K Landis, et al.

Cancer|January 3, 2001

Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomyS R Potter, L A Mangold, M J Shue, et al.

Pageof 129